Moreover, elevated EphA2/ephrin-A1 expression was associated with female gender, reduced smoking status, adenocarcinoma type, well differentiated and p-stage IA NSCLC and EGFR gene mutations[31]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.